Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 25, 2013
View Archived Issues
Vismodegib + FOLFOX evaluated in gastroesophageal carcinoma
Read More
Astex Pharmaceuticals presents phase I results for AT-13387 in GIST
Read More
Sorafenib tested in patients with esophageal and gastroesophageal junction cancer
Read More
German university presents novel plasmin inhibitors
Read More
New acid ceramidase inhibitors patented by CSIC and the Universitat de Barcelona
Read More
Merck & Co. synthesizes new DPP-IV inhibitors
Read More
New inhibitors of pim-1, pim-2 and/or pim-3 presented by CNIO
Read More
Researchers at Tempero Pharmaceuticals design new HDAC9 inhibitors
Read More
Rottapharm synthesizes novel EP4 receptor antagonists
Read More
Lupin presents new PKM2 activators
Read More
Phase III Oral-lyn dossier submitted to Indian government for marketing approval
Read More
Gilead initiates phase III program for tenofovir alafenamide in HIV
Read More
Novel vitamin E derivative suppresses oxidative stress in animal models of traumatic injury
Read More
Amarin launches Vascepa in the U.S.
Read More
Vanda Pharmaceuticals reports results from second phase III RESET study
Read More
Biogen Idec reports topline results from phase III peginterferon beta-1a trial
Read More
Dymista obtains approval in Europe
Read More
Curis doses first patient in phase I trial of CUDC-907
Read More
Selepressin is beneficial in patients with septic shock
Read More
Preclinical studies suggest broad potential for GFT-505 in cirrhosis
Read More
Results reported from phase III Japanese studies of KRN-125
Read More
Biodel reports topline results from study of ultra-rapid-acting insulin analogue candidates
Read More
Orexo and AstraZeneca sign research agreement
Read More
Exelixis launches Cometriq in the U.S.
Read More
Eurocine Vaccines developing Immunose FLU for pediatric market
Read More
Development discontinued of limaprost alfadex for carpal tunnel syndrome
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe